Linagliptin 2.5 mg ""

Linagliptin 2.5 mg
LINALIGLIP is a medication used to treat type 2 diabetes mellitus. LINALIGLIP belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors or gliptins. These medications work by inhibiting the DPP-4 enzyme, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). Incretin hormones help regulate blood sugar levels by stimulating insulin release and reducing glucagon secretion after meals.
LINALIGLIP works by inhibiting the DPP-4 enzyme, which prolongs the action of incretin hormones such as GLP-1 and GIP (glucose-dependent insulinotropic peptide). This leads to increased insulin secretion, reduced glucagon production, and slower digestion of carbohydrates, ultimately resulting in better blood sugar control.
LINALIGLIP is available in strengths of 2.5mg and 5mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-134280